ACICLOVIR 250, 500
Vial Aciclovir 250, 500 mg ( contains strile powder for injection)
|Generic Name of Product||Brand Name||Dosage Form||Strength||Pharmacologic Group||Therapeutic Group||Unit Per Pack|
|Acyclovir||-||Vial||250/500||Herpesvirus infection||Antiviral Agent||20|
Indications And Usage
Herpes simplex infections.
5 mg/kg infused at a constant rate over 1 hour, every 8 hours for 7 days.
Acyclovir Sodium Injection is contraindicated for patients who develop hypersensitivity to acyclovir or valacyclovir.
Approximately 1% of patients receiving intravenous acyclovir have manifested encephalopathic changes characterized by either lethargy, obtundation, tremors, confusion, hallucinations, agitation, seizures, or coma. Acyclovir should be used with caution in those patients who have underlying neurologic abnormalities and those with serious renal, hepatic, or electrolyte abnormalities, or significant hypoxia.
The most frequent adverse reactions reported during administration of acyclovir were inflammation or phlebitis at the injection site
Pregnancy and lactation
Renal and liver Impairment